The Colorado Hospital Association today named Maryjane Wurth its interim president and CEO. Wurth, who was AHA鈥檚 executive vice president and chief operating officer from 2016 until she retired in 2020, will lead CHA for the next several months while its Board conducts a national search for a permanent president and CEO. 
  
鈥淢aryjane is one of the most respected health association executives in our field, and she is a great choice to lead CHA during this transition,鈥 said AHA President and CEO Rick Pollack. 鈥淪he鈥檚 a great partner and will provide thoughtful and strategic leadership. I look forward to working with her to support our Colorado members.鈥 
  
During her tenure at the AHA, Wurth oversaw the creation of the AHA Center for Health Innovation, revamped the business model for AHA鈥檚 for-profit subsidiary, and led a task force that identified new ways to engage hospitals and health systems in the work of the association, among other critical initiatives. 
  
Before coming to the AHA, Wurth was president and CEO of the Illinois Health and Hospital Association. Earlier, she served as COO of the Healthcare Association of New York State, as well as president and CEO of HANYS Solutions, Inc., the association鈥檚 for-profit subsidiary.
 

Related News Articles

Perspective
Public
The job description for the ideal health care leader in coming years might read something like this:Wanted: Bold, compassionate innovator who unites clinical鈥
Headline
The Senate July 29 voted 51-47 along party lines to confirm Susan Monarez as the new director of the Centers for Disease Control and Prevention. Monarez served鈥
Headline
The American Society for Health Care Engineering July 28 announced the recipients of its annual member awards during the 2025 Health Care Facilities Innovation鈥
Perspective
Public
The 2025 AHA Leadership Summit wrapped up on July 22, and as always, it was energizing and inspiring to connect with so many talented and dedicated people鈥
Perspective
Public
Personalized cancer vaccines that are tailored to individual patients, targeting the specific mutations present in their tumors.AI analysis of pathology slides鈥
Headline
President Trump yesterday announced that Casey Means, M.D., has been nominated to be the next U.S. surgeon general.